247 related articles for article (PubMed ID: 34218486)
1. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.
Ferrer I; Andrés-Benito P; Ausín K; Pamplona R; Del Rio JA; Fernández-Irigoyen J; Santamaría E
Brain Pathol; 2021 Nov; 31(6):e12996. PubMed ID: 34218486
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology.
Andrés-Benito P; Carmona M; Pirla MJ; Torrejón-Escribano B; Del Rio JA; Ferrer I
Neuroscience; 2023 May; 518():119-140. PubMed ID: 34757172
[TBL] [Abstract][Full Text] [Related]
3. Proteostatic modulation in brain aging without associated Alzheimer's disease-and age-related neuropathological changes.
Andrés-Benito P; Íñigo-Marco I; Brullas M; Carmona M; Rio JAD; Fernández-Irigoyen J; Santamaría E; Povedano M; Ferrer I
Aging (Albany NY); 2023 May; 15(9):3295-3330. PubMed ID: 37179123
[TBL] [Abstract][Full Text] [Related]
4. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.
Ferrer I; Andrés-Benito P; Ausín K; Cartas-Cejudo P; Lachén-Montes M; Del Rio JA; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742871
[TBL] [Abstract][Full Text] [Related]
6. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
7. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
[TBL] [Abstract][Full Text] [Related]
8. Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.
Stopschinski BE; Del Tredici K; Estill-Terpack SJ; Ghebremedhin E; Yu FF; Braak H; Diamond MI
Acta Neuropathol Commun; 2021 Oct; 9(1):164. PubMed ID: 34635189
[TBL] [Abstract][Full Text] [Related]
9. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.
Rofina JE; Singh K; Skoumalova-Vesela A; van Ederen AM; van Asten AJ; Wilhelm J; Gruys E
Amyloid; 2004 Jun; 11(2):90-100. PubMed ID: 15478464
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis review: Alzheimer's overture guidelines.
Ferrer I
Brain Pathol; 2023 Jan; 33(1):e13122. PubMed ID: 36223647
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
12. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
[TBL] [Abstract][Full Text] [Related]
13. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
[TBL] [Abstract][Full Text] [Related]
14. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
Pooler AM; Polydoro M; Maury EA; Nicholls SB; Reddy SM; Wegmann S; William C; Saqran L; Cagsal-Getkin O; Pitstick R; Beier DR; Carlson GA; Spires-Jones TL; Hyman BT
Acta Neuropathol Commun; 2015 Mar; 3():14. PubMed ID: 25853174
[TBL] [Abstract][Full Text] [Related]
15. Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
Llamas-Rodríguez J; Oltmer J; Greve DN; Williams E; Slepneva N; Wang R; Champion S; Lang-Orsini M; Fischl B; Frosch MP; van der Kouwe AJW; Augustinack JC
J Alzheimers Dis; 2022; 87(3):1379-1399. PubMed ID: 35491780
[TBL] [Abstract][Full Text] [Related]
16. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
[TBL] [Abstract][Full Text] [Related]
17. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
18. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
Aragão Gomes L; Uytterhoeven V; Lopez-Sanmartin D; Tomé SO; Tousseyn T; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Verstreken P; Thal DR
Acta Neuropathol; 2021 Feb; 141(2):173-192. PubMed ID: 33427938
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.
Maeda S; Sahara N; Saito Y; Murayama S; Ikai A; Takashima A
Neurosci Res; 2006 Mar; 54(3):197-201. PubMed ID: 16406150
[TBL] [Abstract][Full Text] [Related]
20. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
